Serveur d'exploration SRAS

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

SARS‐CoV protease inhibitors design using virtual screening method from natural products libraries

Identifieur interne : 004A94 ( Main/Curation ); précédent : 004A93; suivant : 004A95

SARS‐CoV protease inhibitors design using virtual screening method from natural products libraries

Auteurs : Bing Liu [République populaire de Chine] ; Jiaju Zhou [République populaire de Chine]

Source :

RBID : ISTEX:E147A6B1B87821A03A9C019584C9F2DA4660D405

Descripteurs français

English descriptors

Abstract

Two natural products databases, the marine natural products database (MNPD) and the traditional Chinese medicines database (TCMD), were used to find novel structures of potent SARS‐CoV protease inhibitors through virtual screening. Before the procedure, the databases were filtered by Lipinski's ROF and Xu's extension rules. The results were analyzed by statistic methods to eliminate the bias in target‐based database screening toward higher molecular weight compounds for enhancing the hit rate. Eighteen lead compounds were recommended by the screening procedure. They were useful for experimental scientists in prioritizing drug candidates and studying the interaction mechanism. The binding mechanism was also analyzed between the best screening compound and the SARS protein. © 2005 Wiley Periodicals, Inc. J Comput Chem 26: 484–490, 2005

Url:
DOI: 10.1002/jcc.20186

Links toward previous steps (curation, corpus...)


Links to Exploration step

ISTEX:E147A6B1B87821A03A9C019584C9F2DA4660D405

Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">SARS‐CoV protease inhibitors design using virtual screening method from natural products libraries</title>
<author>
<name sortKey="Liu, Bing" sort="Liu, Bing" uniqKey="Liu B" first="Bing" last="Liu">Bing Liu</name>
</author>
<author>
<name sortKey="Zhou, Jiaju" sort="Zhou, Jiaju" uniqKey="Zhou J" first="Jiaju" last="Zhou">Jiaju Zhou</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:E147A6B1B87821A03A9C019584C9F2DA4660D405</idno>
<date when="2005" year="2005">2005</date>
<idno type="doi">10.1002/jcc.20186</idno>
<idno type="url">https://api.istex.fr/ark:/67375/WNG-M6MK8DC8-T/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000687</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000687</idno>
<idno type="wicri:Area/Istex/Curation">000687</idno>
<idno type="wicri:Area/Istex/Checkpoint">001955</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">001955</idno>
<idno type="wicri:doubleKey">0192-8651:2005:Liu B:sars:cov:protease</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:15693056</idno>
<idno type="wicri:Area/PubMed/Corpus">002904</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002904</idno>
<idno type="wicri:Area/PubMed/Curation">002904</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002904</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002513</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002513</idno>
<idno type="wicri:Area/Ncbi/Merge">000D65</idno>
<idno type="wicri:Area/Ncbi/Curation">000D65</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000D65</idno>
<idno type="wicri:doubleKey">0192-8651:2005:Liu B:sars:cov:protease</idno>
<idno type="wicri:Area/Main/Merge">004E22</idno>
<idno type="wicri:Area/Main/Curation">004A94</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main">SARS‐CoV protease inhibitors design using virtual screening method from natural products libraries</title>
<author>
<name sortKey="Liu, Bing" sort="Liu, Bing" uniqKey="Liu B" first="Bing" last="Liu">Bing Liu</name>
<affiliation wicri:level="1">
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>State Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences Beijing 100080</wicri:regionArea>
<wicri:noRegion>Chinese Academy of Sciences Beijing 100080</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Graduate School of the Chinese Academy of Sciences, Beijing 100039</wicri:regionArea>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Zhou, Jiaju" sort="Zhou, Jiaju" uniqKey="Zhou J" first="Jiaju" last="Zhou">Jiaju Zhou</name>
<affiliation wicri:level="1">
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>State Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences Beijing 100080</wicri:regionArea>
<wicri:noRegion>Chinese Academy of Sciences Beijing 100080</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<country wicri:rule="url">République populaire de Chine</country>
</affiliation>
<affiliation wicri:level="1">
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Correspondence address: State Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences Beijing 100080</wicri:regionArea>
<wicri:noRegion>Chinese Academy of Sciences Beijing 100080</wicri:noRegion>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j" type="main">Journal of Computational Chemistry</title>
<title level="j" type="alt">JOURNAL OF COMPUTATIONAL CHEMISTRY</title>
<idno type="ISSN">0192-8651</idno>
<idno type="eISSN">1096-987X</idno>
<imprint>
<biblScope unit="vol">26</biblScope>
<biblScope unit="issue">5</biblScope>
<biblScope unit="page" from="484">484</biblScope>
<biblScope unit="page" to="490">490</biblScope>
<biblScope unit="page-count">7</biblScope>
<publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2005-04-15">2005-04-15</date>
</imprint>
<idno type="ISSN">0192-8651</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0192-8651</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Algorithms</term>
<term>Biological Products (chemistry)</term>
<term>Combinatorial Chemistry Techniques</term>
<term>Cysteine Endopeptidases</term>
<term>Databases, Factual</term>
<term>Drug Design</term>
<term>Drug Evaluation, Preclinical</term>
<term>Endopeptidases</term>
<term>Medicine, Chinese Traditional</term>
<term>Models, Molecular</term>
<term>Molecular Conformation</term>
<term>Molecular Structure</term>
<term>Protease Inhibitors (chemistry)</term>
<term>SARS Virus (enzymology)</term>
<term>Viral Proteins (antagonists & inhibitors)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Algorithmes</term>
<term>Bases de données factuelles</term>
<term>Conception de médicament</term>
<term>Conformation moléculaire</term>
<term>Cysteine endopeptidases</term>
<term>Endopeptidases</term>
<term>Inhibiteurs de protéases ()</term>
<term>Modèles moléculaires</term>
<term>Médecine traditionnelle chinoise</term>
<term>Produits biologiques ()</term>
<term>Protéines virales (antagonistes et inhibiteurs)</term>
<term>Structure moléculaire</term>
<term>Techniques de chimie combinatoire</term>
<term>Virus du SRAS (enzymologie)</term>
<term>Évaluation préclinique de médicament</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="antagonists & inhibitors" xml:lang="en">
<term>Viral Proteins</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="chemistry" xml:lang="en">
<term>Biological Products</term>
<term>Protease Inhibitors</term>
</keywords>
<keywords scheme="MESH" qualifier="antagonistes et inhibiteurs" xml:lang="fr">
<term>Protéines virales</term>
</keywords>
<keywords scheme="MESH" qualifier="enzymologie" xml:lang="fr">
<term>Virus du SRAS</term>
</keywords>
<keywords scheme="MESH" qualifier="enzymology" xml:lang="en">
<term>SARS Virus</term>
</keywords>
<keywords scheme="Teeft" xml:lang="en">
<term>Active pocket</term>
<term>Active site</term>
<term>Algorithms</term>
<term>Binding mechanism</term>
<term>Bioactivity data</term>
<term>Chem</term>
<term>Chinese academy</term>
<term>Combinatorial Chemistry Techniques</term>
<term>Crucial role</term>
<term>Cysteine Endopeptidases</term>
<term>Database</term>
<term>Databases, Factual</term>
<term>Dock energy score distribution</term>
<term>Drug Design</term>
<term>Drug Evaluation, Preclinical</term>
<term>Endopeptidases</term>
<term>Energy scores</term>
<term>Experimental scientists</term>
<term>Exponential decay</term>
<term>Indigowoad root</term>
<term>Inhibitor</term>
<term>Interaction mechanism</term>
<term>Logp</term>
<term>Logp dock autodock</term>
<term>Medicine, Chinese Traditional</term>
<term>Mnpd</term>
<term>Models, Molecular</term>
<term>Molecular Conformation</term>
<term>Molecular Structure</term>
<term>Natural products databases</term>
<term>Natural sources</term>
<term>Online issue</term>
<term>Prioritizing drug candidates</term>
<term>Proc natl acad</term>
<term>Protease</term>
<term>Protease inhibitors design</term>
<term>Sars</term>
<term>Sars protein</term>
<term>Schematic representation</term>
<term>Small molecules</term>
<term>Statistic methods</term>
<term>Swordlike atractylodes</term>
<term>Target protein</term>
<term>Tcmd</term>
<term>Traditional chinese medicines database</term>
<term>Virtual screening</term>
<term>Wiley periodicals</term>
<term>Zhou</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Algorithmes</term>
<term>Bases de données factuelles</term>
<term>Conception de médicament</term>
<term>Conformation moléculaire</term>
<term>Cysteine endopeptidases</term>
<term>Endopeptidases</term>
<term>Inhibiteurs de protéases</term>
<term>Modèles moléculaires</term>
<term>Médecine traditionnelle chinoise</term>
<term>Produits biologiques</term>
<term>Structure moléculaire</term>
<term>Techniques de chimie combinatoire</term>
<term>Évaluation préclinique de médicament</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Two natural products databases, the marine natural products database (MNPD) and the traditional Chinese medicines database (TCMD), were used to find novel structures of potent SARS‐CoV protease inhibitors through virtual screening. Before the procedure, the databases were filtered by Lipinski's ROF and Xu's extension rules. The results were analyzed by statistic methods to eliminate the bias in target‐based database screening toward higher molecular weight compounds for enhancing the hit rate. Eighteen lead compounds were recommended by the screening procedure. They were useful for experimental scientists in prioritizing drug candidates and studying the interaction mechanism. The binding mechanism was also analyzed between the best screening compound and the SARS protein. © 2005 Wiley Periodicals, Inc. J Comput Chem 26: 484–490, 2005</div>
</front>
</TEI>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Main/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004A94 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Curation/biblio.hfd -nk 004A94 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    Main
   |étape=   Curation
   |type=    RBID
   |clé=     ISTEX:E147A6B1B87821A03A9C019584C9F2DA4660D405
   |texte=   SARS‐CoV protease inhibitors design using virtual screening method from natural products libraries
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021